by Igor Hajdukovic | Oct 9, 2026 | Uncategorized
A plasma device for periocular rejuvenation should be assessed by more than its proposed cosmetic effect. Around the eyes, the treatment area, energy delivery and the device’s intended use all shape the clinical decision.Clinicians considering less invasive approaches...
by Igor Hajdukovic | Oct 8, 2026 | Uncategorized
A plasma therapy protocol can be clinically sound for one intervention and misleading for another. That distinction matters when developing a plasma therapy for meibomian gland dysfunction protocol: direct-current plasma devices and platelet-rich plasma (PRP) eye...
by Igor Hajdukovic | Oct 7, 2026 | Uncategorized
When considering combining plasma therapy with biostimulators, first clarify what “plasma” means. Platelet-rich plasma (PRP) is prepared from a patient’s blood, while direct-current plasma devices deliver energy to tissue. These are different modalities, with distinct...
by Igor Hajdukovic | Oct 6, 2026 | Uncategorized
A medical grade plasma lift is defined by clinical controls, not by the wording on a device page. Since “medical grade” is used inconsistently in aesthetic-device marketing, the label alone doesn’t explain how a system works, who it’s intended for, or what regulatory...
by Igor Hajdukovic | Oct 5, 2026 | Uncategorized
A device’s pen-like shape doesn’t make it clinically appropriate for skin lifting. When evaluating a medical plasma device for skin lifting, focus on how it delivers energy, its documented intended use, and the controls and instructions that guide treatment. These...
by Igor Hajdukovic | Oct 4, 2026 | Uncategorized
A device marketed as a plasma pen isn’t automatically appropriate for clinical wrinkle care. Before adopting a professional plasma pen for wrinkle reduction, assess its intended use, Health Canada licensing, patient suitability and the practitioner’s scope and...
